Free Access
| Issue |
Med Sci (Paris)
Volume 22, Number 3, Mars 2006
|
|
|---|---|---|
| Page(s) | 229 - 230 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2006223229 | |
| Published online | 15 March 2006 | |
- Mikkola ML, Thesleff I. Ectodysplasin signaling in development. Cytokine Growth Factor Rev 2003; 14 : 211–24. [Google Scholar]
- Headon DJ, Emmal SA, Ferguson BM, et al. Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature 2001; 414 : 913–6. [Google Scholar]
- Yan M, Zhang Z, Brady JR, et al. Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr Biol 2002; 12 : 409–13. [Google Scholar]
- Kumar A, Eby MT, Sinha S, et al. The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A. J Biol Chem 2001; 276 : 2668–77. [Google Scholar]
- Doffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001; 27 : 277–85. [Google Scholar]
- Morlon A, Munnich A, Smahi A. TAB2, TRAF6 and TAK1 are involved in NF-[kappa]B activation induced by the TNF-receptor, Edar and its adaptator Edaradd. Hum Mol Genet 2005; 14 : 3751–7. [Google Scholar]
- Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 2002; 22 : 7158–67. [Google Scholar]
- Takaesu G, Kishida S, Hiyama A, et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 2000; 5 : 649–58. [Google Scholar]
- Mizukami J, Takaesu G, Akatsuka H, et al. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol 2002; 22 : 992–1000. [Google Scholar]
- Courtois G, Smahi A, Reichenbach J, et al. hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003; 112 : 1108–15. [Google Scholar]
- Naito A, Azuma S, Tanaka S, et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4 : 353–62. [Google Scholar]
- Naito A, Yoshida H, Nishioka E, et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci USA 2002; 99 : 8766–71. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.